ArticleBreast cancer research : BCR2019

Prexasertib treatment induces homologous recombination deficiency and synergizes with olaparib in triple-negative breast cancer cells.

Chinnadurai Mani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.